Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
90.25
-2.43 (-2.62%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $7.96 billion as of September 18, 2026. Its market cap has increased by 775.43% in one year.
Market Cap
7.96B
Enterprise Value
6.81B
1-Year Change
775.43%
Ranking
Category
Stock Price
$90.25
ChartMarket Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $7.96B, an increase of 7,024.16%. That is a compound annual growth rate of 50.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 7.96B | 213.06% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 9.39B |
| Protagonist Therapeutics | 9.25B |
| ABIVAX Société Anonyme | 9.10B |
| ImmunityBio | 8.99B |
| Vaxcyte | 8.65B |
| Caris Life Sciences | 8.47B |
| Praxis Precision Medicines | 8.35B |
| TG Therapeutics | 8.07B |